Jeunesse
Inc. Institute of Longevity Medicine
Darryl See, M.D. Director, Bioassay
Laboratory
Preliminary Report
(additional test results to follow)
Transfer Factor™
Testing
Background and rationale:
1) Cancer is the second leading cause of death in the US. The rate of nearly
every type of cancer is on the rise. Despite billions of dollars in research,
the mortality rate has remained nearly unchanged since the 1960's using
conventional treatments such as radiation, surgery and chemotherapy. Thus,
there is considerable interest in using immune modulation as an adjuvant
for cancer therapy. Natural killer cells are particularly important in
destroying cancer cells.
 Purpose
of study: 1) To determine the in vitro anti-cancer effects of Transfer
Factor™ and Transfer Factor Plus™ using PBMC isolated from human volunteers
and assaying the increased ability of the NK cell population to kill K562
erythroleukemic cells.
Methods: 1) PBMC killing
of K562 (erythroleukemic) cells
Results:
1) Transfer Factor™ increased NK-cell killing by 103%
Transfer Factor Plus™ increased NK-cell killing by 248% |
Conclusions: Transfer Factor™
and Transfer Factor Plus™ induced immune-based lysis of K562 cells at a
level unprecedented in the director's experience or in the known medical
literature. Since NK cell function is so crucial in killing cancer cells,
these products are ideal candidates for cancer adjuvant therapy. In addition,
NK cells form a first line of defense against infections from viruses and
certain other microorganisms. Killing assays against K562 cells have also
been correlated with increased activity against chronic and acute infections
as well.
Darryl See, M.D.
Director, Bioassay Laboratory
Institute of Longevity Medicine
|
|
Nutraceutical induced increase in Natural Killer
cell activity
|
| Nutriceutical |
% Rise in Natural
Killer cell activity |
| Transfer Factor Plus™ |
248 %
|
| Transfer Factor™ |
103 % |
| IP6 (highest
of group previously tested) |
49 % |
| Plant Polysaccharide
Formula |
48 % |
| Echinacea |
43 % |
| Shiitake Mushroom |
42 % |
| Cordeceps Formula |
28 % |
| Bovine Colostrum |
23 % |
| Phytonutrient Formula |
21 % |
| Endocrine System Formula |
16 % |
| Aloe Vera Concentrate
(acemannan) |
15 % |
| Noni (Morinda
Citrafolia) |
15 % |
Note: Over the years, Jeunesse Inc.
has tested 196 nutraceuticals. 152 of these products increased effectiveness
from 0 to 10%. Only 44 products did better than 10%. 40% of
these products were too toxic to use without caution. Until now, IP6 showed
the highest increase at 49%. Transfer Factor™
has been shown to be the most powerful product on the market, with a toxicity
level of ZERO.
Transfer Factor Study
with 20 Cancer Patients
Darryl
See, M.D. conducted the following studies.
Twenty
patients, 12 men and 8 women, were selected for this in vivo study.
The average age was 49.3. The twenty individuals were each level
3 or level 4 cancer patients. Each patient was basically sent home
by his or her oncologist to die. The average life expectancy was
3.7 months. The protocol was to place each patient on 9 capsules
per day of Transfer Factor Plus™. The patients were given a number
of other general nutrients*. After eight months, 16 of these individuals
were still living and were either in remission, improving or stabilized.
The
baseline for natural killer cell function was 6.4. Within 4 weeks
the average NK Cell function was increased to 25.7 and in 6 months it increased
to 27.6. This represented a 400% increase in NK Cell function.
This is an ongoing study. This study has been submitted to a peer
reviewed publication.
*Antioxidants,
Digestive Enzymes, Probiotics and multi-vitamins.
The
following study was conducted at the Institute of Longevity. The
purpose of the study was to examine the synergistic effects of the components
of Transfer Factor Plus™. Each component was tested separately and
then tested as a whole unit. Together the proprietary blend increased
NK Cell functions more than the sum total of all of the ingredients tested
separately. This study indicates that the intelligence contained
in Transfer Factor™ has an enhancing effect on other nutrients.
In
vitro study:
Ingredient
10 GM /ml NK Function
PBMC
(Control) 25.6%
Zinc
26.8% NS
Proprietary
Blend 59.9% <0.02 (Mushrooms etc)
Zinc
+Prop. Blend 95.4 <0.01
Transfer
Factor™ alone 128.5% <0.01
Complete
Prod. (Transfer Factor Plus™) 273.6% <0.01
The
sum of the individual product is less than the Complete Product (Transfer
Factor Plus™).
There
is synergy in having a combination of Transfer Factor Plus™.
The information has not been
evaluated by the FDA or by 4Life™ Research. We do not claim that
4Life™ products directly prevent, or cure any disease. We do not
suggest that anyone should replace traditional medical treatment with our
products. 4Life™ products are promoted for their ability to enhance
the effectiveness of our natural immune system functions. On this
web site you will be exposed to many testimonies and nutritional ideas.
We encourage you to use common sense and prudence in evaluating testimonies.
Testimonies can be based on "placebo effects," which basically means that
you can experience temporary results just because you really believe you
will. Research can be complicated to translate into real life situations.
Even medical doctors may disagree on certain subjects. It is our
desire to expose you to many different ideas for your consideration.
Our focus is on supporting the immune system, which can assist your body
in the healing process. The testimonies and information on this web
site only represent the opinions of the individuals involved. We
encourage you to use common sense in your expectations in consuming any
nutritional product.
All material provided in
this site is provided for educational purposes only. The information provided
may not be relied upon for diagnosis or treatment of any disease or medical
condition. Seek advice from your health care professional regarding the
applicability of any information, opinion or recommendation for diagnosis
or treatment of any symptoms or medical condition. Statements about products
and health conditions have not been evaluated by the U.S. Food & Drug
Administration. Products of 4Life Research are not intended to diagnose,
treat, cure, or prevent any disease.
.
......
